Archives

  • 2026-06
  • 2026-05
  • 2026-04
  • 2026-03
  • 2026-02
  • 2026-01
  • 2025-12
  • 2025-11
  • 2025-10
  • 2023-07
  • 2023-06
  • 2023-05
  • 2023-04
  • 2023-03
  • 2023-02
  • 2023-01
  • 2022-12
  • 2022-11
  • 2022-10
  • 2022-09
  • 2022-08
  • 2022-07
  • 2022-06
  • 2022-05
  • 2022-04
  • 2022-03
  • 2022-02
  • 2022-01
  • 2021-12
  • 2021-11
  • 2021-10
  • 2021-09
  • 2021-08
  • 2021-07
  • 2021-06
  • 2021-05
  • 2021-04
  • 2021-03
  • 2021-02
  • 2021-01
  • 2020-12
  • 2020-11
  • 2020-10
  • 2020-09
  • 2020-08
  • 2020-07
  • 2020-06
  • 2020-05
  • 2020-04
  • 2020-03
  • 2020-02
  • 2020-01
  • 2019-12
  • 2019-11
  • 2019-10
  • 2019-09
  • 2019-08
  • 2019-07
  • 2019-06
  • 2019-05
  • 2019-04
  • 2018-07

    • Uridine, Trisodium Salt: RNA Biosynthesis and PRINT Applicat

    2026-06-03

    Uridine, Trisodium Salt: RNA Biosynthesis and PRINT Applications

    Executive Summary: Uridine, Trisodium Salt (B1473) is a high-purity nucleoside analog critical for RNA biosynthesis and site-specific RNA-guided transgene insertion workflows (APExBIO product information). This compound serves as an efficient RNA precursor, supporting enzymatic synthesis pathways underpinning emerging genetic engineering technologies such as PRINT (Zhang et al., 2024). Its excellent solubility in water and DMSO, combined with robust quality control (HPLC, NMR), ensures reproducibility in RNA metabolism and vascular contractility assays. Recent advances show that non-LTR retroelement-based genome editing leverages uridine-rich RNA templates for precise transgene integration at human safe-harbor loci. Cross-referencing with prior content, this article provides an updated, granular protocol and mechanistic analysis beyond previously published application notes.

    Biological Rationale

    Uridine, Trisodium Salt is the trisodium salt form of uridine, a key pyrimidine nucleoside. It is integral to the biosynthesis of RNA by providing uridine monophosphate (UMP) for RNA polymerase-driven chain elongation. In eukaryotic cells, uridine is rapidly phosphorylated and incorporated into nascent RNA strands, making it a direct substrate for in vitro transcription and cellular labeling studies (Zhang et al., 2024). This nucleoside analog's high purity (99.95%) minimizes confounding background in sensitive metabolic or transgenesis assays. Additionally, uridine-containing compounds are essential for the function of retroelement reverse transcriptases, which require intact ribonucleoside triphosphate pools to mediate cDNA synthesis during target-primed reverse transcription (TPRT).

    Mechanism of Action of Uridine, Trisodium Salt

    As a nucleoside analog, Uridine, Trisodium Salt acts as an energy-rich precursor in enzymatic RNA biosynthesis. Upon dissolution in aqueous media (solubility ≥58.6 mg/mL in water), it is readily available for kinase-mediated phosphorylation to UTP. UTP is then incorporated by RNA polymerases during transcription reactions. In PRINT (Precise RNA-mediated Insertion of Transgenes), in vitro-transcribed RNAs—often synthesized using uridine analogs—act as templates for safe-harbor transgene insertion via non-LTR retroelement machinery (Zhang et al., 2024). The stability and purity of uridine are crucial for generating long, full-length RNA templates necessary for efficient cDNA synthesis and genome integration. Furthermore, uridine may influence contractile responses in vascular tissues, supporting its use as a vasodilation research compound (APExBIO).

    Evidence & Benchmarks

    • Uridine, Trisodium Salt supports high-yield RNA synthesis with a purity of 99.95%, reducing batch variability and off-target effects (product specification).
    • PRINT technology achieves >50% stable, site-specific transgene insertion in human cells using in vitro-transcribed RNA templates synthesized with uridine analogs (Zhang et al., 2024).
    • The compound is soluble at ≥58.6 mg/mL in water and ≥71.43 mg/mL in DMSO, enabling flexible protocol adaptation (APExBIO).
    • Quality control measures, including HPLC and NMR, verify batch-to-batch consistency and absence of contaminating nucleotides (APExBIO).
    • Non-LTR retroelement-mediated cDNA synthesis is dependent on robust, full-length RNA templates containing uridine, as demonstrated in TPRT biochemical assays (Zhang et al., 2024, Fig. 1).

    This article updates protocol-level guidance from Uridine, Trisodium Salt: Empowering RNA Biosynthesis Precision, with a focus on PRINT-specific template design and stability, whereas the previous article emphasized troubleshooting and general workflow setup.

    Applications, Limits & Misconceptions

    Uridine, Trisodium Salt is validated for:

    • In vitro transcription reactions for generating RNA templates (including those required for PRINT).
    • RNA metabolism studies, including pulse-chase labeling and enzymatic pathway assays.
    • Vascular biology assays where uridine's vasodilatory or contractile effects are modeled.

    However, its use is limited to research applications and is not suitable for diagnostic or therapeutic deployment. The compound is not intended for direct in vivo gene therapy or clinical RNA supplementation. For a deeper mechanistic contrast, see Uridine, Trisodium Salt: Enhancing RNA Biosynthesis for PRINT Precision, which details advanced assay strategies; this current article provides protocol and stability guidance for laboratory workflows.

    Common Pitfalls or Misconceptions

    • Assuming all nucleoside analogs are interchangeable: Substituting uridine with cytidine or adenosine analogs may impair RNA template function in PRINT (Zhang et al., 2024).
    • Overlooking storage conditions: Long-term storage of uridine solutions leads to hydrolysis and should be avoided; use freshly prepared solutions (APExBIO).
    • Using low-purity uridine: Impurities may introduce spurious bands or truncated RNA products in sensitive TPRT or transcription assays (APExBIO).
    • Expecting direct therapeutic effects: Research-grade uridine trisodium salt is not formulated for clinical or diagnostic use.

    Workflow Integration & Parameters

    Uridine, Trisodium Salt (B1473) integrates smoothly into RNA synthesis and genome engineering pipelines. Compared to Uridine, Trisodium Salt: Empowering Precision RNA Transgenesis, which explores translational perspectives, this section prioritizes actionable protocol details for maximal reproducibility.

    Protocol Parameters

    • Dissolution for stock: Dissolve at ≥58.6 mg/mL in nuclease-free water or ≥71.43 mg/mL in DMSO at room temperature; gentle warming and sonication may improve ethanol solubility to ≥3.9 mg/mL.
    • Storage: Store solid at -20°C; ship on blue ice. Prepare fresh working solutions; avoid repeated freeze-thaw cycles.
    • RNA synthesis: Use freshly prepared uridine trisodium salt for in vitro transcription with T7, SP6, or similar polymerases. Typical final concentrations: 1–2 mM UTP in reaction mix.
    • PRINT template design: Ensure uridine-rich regions are correctly encoded in template RNAs for efficient TPRT-mediated transgene insertion (Zhang et al., 2024).
    • Quality control: Confirm lot purity by HPLC or NMR if possible; reference batch data from APExBIO when troubleshooting.

    Conclusion & Outlook

    Uridine, Trisodium Salt (B1473) from APExBIO is a rigorously validated nucleoside analog for RNA biosynthesis and precision genome engineering workflows. Its use is central to PRINT-based site-specific transgene insertion, as robust uridine-containing RNA templates are required for optimal cDNA synthesis and genomic integration (Zhang et al., 2024). Looking ahead, the established role of uridine in RNA metabolism and non-LTR retroelement-driven genome editing suggests continued utility for this compound in next-generation research protocols. As PRINT and related RNA-mediated technologies mature, the demand for high-purity, reproducible uridine analogs will likely increase, with APExBIO B1473 positioned as a reference standard for such applications.